Who owns SOLID BIOSCIENCES INC?
- Ticker: SLDB
- CUSIP Number: 83422e204
Tip: Access positions for across all investors
Analyze quarterly positions in Solid Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Solid Biosciences stock
Who bought or sold SOLID BIOSCIENCES INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Perceptive Advisors | 6.9M | $92M | 98% | Mar 2024 |
|
| RA Capital Management | 4.3M | $58M | 26% | Mar 2024 |
|
| Bain Capital Life Sciences Investors | 4.0M | $54M | 29% | Mar 2024 |
|
| Adage Capital Partners GP | 2.5M | $34M | 100% | Mar 2024 |
|
| Artal Group | 2.5M | $33M | 175% | Mar 2024 |
|
| Deerfield Management Company | 2.3M | $30M | 100% | Mar 2024 |
|
| Henderson Group | 1.8M | $24M | 100% | Mar 2024 |
|
| Vanguard Group | 1.2M | $17M | 284% | Mar 2024 |
|
| Finepoint Capital | 961k | $13M | 0% | Mar 2024 |
|
| Laurion Capital Management | 928k | $12M | 0% | Mar 2024 |
|
| Millennium Management | 733k | $9.8M | 100% | Mar 2024 |
|
| Monashee Investment Management | 620k | $8.3M | 100% | Mar 2024 |
|
| Walleye Trading Advisors | 576k | $7.7M | 363% | Mar 2024 |
|
| Alyeska Investment Group | 415k | $5.5M | -35% | Mar 2024 |
|
| BlackRock | 307k | $4.1M | 134% | Mar 2024 |
|
| Geode Capital Management | 238k | $3.2M | 132% | Mar 2024 |
|
| Susquehanna International | 217k | $2.9M | 100% | Mar 2024 |
|
| Goldman Sachs Group | 204k | $2.7M | 100% | Mar 2024 |
|
| ADAR1 Capital Management | 203k | $2.7M | 20220% | Mar 2024 |
|
| Qube Research & Technologies | 131k | $1.7M | 13064700% | Mar 2024 |
|
| Two Sigma Investments | 87k | $1.2M | 135% | Mar 2024 |
|
| Jane Street | 86k | $1.1M | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 70k | $936k | 52740% | Mar 2024 |
|
| Dimensional Fund Advisors | 66k | $873k | 31% | Mar 2024 |
|
| Citadel Advisors | 56k | $744k | 100% | Mar 2024 |
|
| Bridgeway Capital Management | 51k | $680k | 42% | Mar 2024 |
|
| Man Group | 49k | $652k | 100% | Mar 2024 |
|
| Citigroup | 48k | $636k | 100% | Mar 2024 |
|
| Northern Trust | 42k | $558k | 267% | Mar 2024 |
|
| Marathon Trading Investment Management | 37k | $497k | 100% | Mar 2024 |
|
| Bank of America Corporation | 30k | $404k | 667% | Mar 2024 |
|
| American Century Companies | 25k | $329k | 100% | Mar 2024 |
|
| ExodusPoint Capital Management | 24k | $321k | 100% | Mar 2024 |
|
| Balyasny Asset Management | 24k | $313k | 100% | Mar 2024 |
|
| Morgan Stanley | 22k | $296k | 382% | Mar 2024 |
|
| Two Sigma Advisers | 15k | $193k | 100% | Mar 2024 |
|
| UBS Group | 14k | $190k | 254% | Mar 2024 |
|
| Raymond James Financial Services Advisors | 13k | $177k | 100% | Mar 2024 |
|
| Charles Schwab Investment Management | 10k | $137k | 100% | Mar 2024 |
|
| Barclays | 4.4k | $59k | 0% | Mar 2024 |
|
| TD Waterhouse Canada | 180.00 | $3.0k | 100% | Mar 2024 |
|
| Wells Fargo & Company | 164.00 | $2.2k | 119% | Mar 2024 |
|
| First Manhattan | 133.00 | $1.8k | 0% | Mar 2024 |
|
| Royal Bank of Canada | 66.00 | $999.999000 | -98% | Mar 2024 |
|
| Advisor Group Holdings | 30.00 | $398.751000 | 0% | Mar 2024 |
|
Who sold out of Solid Biosciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Bank Of Montreal | Dec 2023 | 132k | $901k |
| AJOVista | Dec 2023 | 3.8k | $23k |
| Lazard Asset Management | Sep 2023 | 2.3k | $0 |
| Tower Research Capital | Sep 2023 | 1.5k | $3.8k |
| Simplex Trading | Dec 2023 | 537.00 | $3.0k |
| FMR | Sep 2023 | 300.00 | $756.000000 |
| Group One Trading | Sep 2023 | 214.00 | $539.001800 |